David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Aerospace
GE
|
+$570M |
| 2 |
Meta Platforms (Facebook)
META
|
+$469M |
| 3 |
TWX
Time Warner Inc
TWX
|
+$342M |
| 4 |
Merck
MRK
|
+$322M |
| 5 |
MON
Monsanto Co
MON
|
+$249M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$434M |
| 2 |
Netflix
NFLX
|
+$301M |
| 3 |
Alibaba
BABA
|
+$245M |
| 4 |
Verizon
VZ
|
+$235M |
| 5 |
Tesla
TSLA
|
+$230M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.95% |
| 2 | Healthcare | 11.57% |
| 3 | Consumer Discretionary | 9.23% |
| 4 | Communication Services | 8.8% |
| 5 | Industrials | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Allstate
ALL
$64.2B
| $29.6M | 0.04% |
282,859
-47,087
| -14% | -$4.64M |
|
502
Kroger
KR
$35.5B
| $29.5M | 0.04% |
1,076,008
-584,863
| -35% | -$13.6M |
|
503
Bunge Global
BG
$21.7B
| $29.5M | 0.04% |
439,724
+106,348
| +32% | +$7.23M |
|
504
CALL
Starbucks
SBUX
$122B
| $29.4M | 0.04% |
512,800
+230,100
| +81% | +$13M |
|
505
CALL
Marriott International
MAR
$92.9B
| $29.3M | 0.04% |
216,200
+33,600
| +18% | +$4.13M |
|
506
Tower Semiconductor
TSEM
$25.2B
| $29.3M | 0.04% |
859,811
-91,470
| -10% | -$3.03M |
|
|
B
507
PUT
Barrick Mining
B
$78.3B
| $29.2M | 0.04% |
2,021,200
+1,040,200
| +106% | +$15.3M |
|
508
EnerSys
ENS
$6.84B
| $29.1M | 0.04% |
417,686
+155,307
| +59% | +$10.6M |
|
509
Fortinet
FTNT
$113B
| $29M | 0.04% |
3,318,815
+1,752,875
| +112% | +$14.3M |
|
510
CALL
Ulta Beauty
ULTA
$22.4B
| $29M | 0.04% |
129,600
+9,400
| +8% | +$1.99M |
|
511
CALL
Chevron
CVX
$403B
| $28.9M | 0.04% |
230,500
+47,200
| +26% | +$5.6M |
|
512
Franklin Templeton
BEN
$17.4B
| $28.9M | 0.04% |
665,851
+534,737
| +408% | +$23.2M |
|
513
Union Pacific
UNP
$183B
| $28.8M | 0.04% |
214,826
-813,335
| -79% | -$98.1M |
|
514
Magna International
MGA
$19.5B
| $28.8M | 0.04% |
507,844
+292,107
| +135% | +$16.1M |
|
515
Expeditors International
EXPD
$24.4B
| $28.6M | 0.04% |
441,396
+384,124
| +671% | +$23.5M |
|
|
MGLN
516
DELISTED
Magellan Health Services, Inc.
MGLN
| $28.5M | 0.04% |
295,679
+81,893
| +38% | +$7.24M |
|
517
Conduent
CNDT
$250M
| $28.2M | 0.04% |
1,747,949
+638,022
| +57% | +$9.99M |
|
518
CALL
McDonald's
MCD
$192B
| $28.2M | 0.04% |
164,000
-125,700
| -43% | -$21.1M |
|
519
Kirby Corp
KEX
$7.39B
| $28.2M | 0.04% |
421,925
-81,086
| -16% | -$5.31M |
|
|
TWTR
520
CALL
DELISTED
Twitter, Inc.
TWTR
| $28.2M | 0.04% |
1,172,600
+110,000
| +10% | +$2.26M |
|
|
CBPX
521
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $28M | 0.04% |
995,677
-120,684
| -11% | -$3.27M |
|
522
Teva Pharmaceuticals
TEVA
$43.5B
| $28M | 0.04% |
1,477,972
-29,534
| -2% | -$444K |
|
523
PUT
Northrop Grumman
NOC
$78.3B
| $28M | 0.04% |
91,200
+8,100
| +10% | +$2.43M |
|
|
SYNH
524
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $28M | 0.04% |
641,653
-485,770
| -43% | -$22.7M |
|
525
Steel Dynamics
STLD
$32.8B
| $27.9M | 0.04% |
647,565
-560,827
| -46% | -$21.6M |
|
Similar funds
David Shaw's Q4 2017 Portfolio in Review
As of Q4 2017, David Shaw held 3,940 positions worth $72.6B, up 12% from $65.1B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw deployed $3.73B of net new capital in Q4 2017, opening 507 new positions and adding to 1,441 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $434M trimmed.
- David Shaw's largest Q4 2017 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,178,870 shares worth $88.8M.
- David Shaw added most to GE Aerospace in Q4 2017, an estimated $570M increase.
- David Shaw's biggest Q4 2017 reduction was Apple, cutting an estimated $434M.
- David Shaw fully exited Tesla in Q4 2017, selling an estimated $230M.
- David Shaw's ten largest holdings make up 9.5% of its $72.6B portfolio in Q4 2017.
- David Shaw opened 507 new positions and closed 394 in Q4 2017.
- David Shaw's portfolio value rose 12% quarter-over-quarter to $72.6B.
Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.